Ftse Mib
34.899,93
0,49%
DAX
20.401,94
-0,06%
S&P 500
6.084,19
0,82%
NASDAQ
20.034,89
0,00%
Bitcoin
101.291,28
0,10%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Navamedic Asa (0FDB) Navamedic Asa (0FDB) Notizie

0FDB

Navamedic Asa (0FDB)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0FDB
DataOraFonteTitoloSimboloCompagnia
21/12/202317:29PR Newswire (US)Navamedic ASA: Renewed contract signed with Vitaflo International LimitedLSE:0FDBNavamedic Asa
13/12/202319:18PR Newswire (US)Navamedic and Orion Corporation sign non-binding term sheet for Flexilev®in EuropeLSE:0FDBNavamedic Asa
01/11/202308:14PR Newswire (US)Navamedic ASA: Record high quarter with above 50 percent growthLSE:0FDBNavamedic Asa
27/10/202311:52PR Newswire (US)Navamedic ASA: Invitation to 2023 3rd quarter presentationLSE:0FDBNavamedic Asa
30/08/202313:20PR Newswire (US)Navamedic ASA - Registration of share capital increaseLSE:0FDBNavamedic Asa
18/08/202312:50PR Newswire (US)Navamedic ASA - Mandatory notification of trade by primary insiderLSE:0FDBNavamedic Asa
18/08/202312:27PR Newswire (US)NAVAMEDIC ASA: Resolution to increase the share capital in connection with exercise of employee optionsLSE:0FDBNavamedic Asa
11/08/202308:41PR Newswire (US)Navamedic ASA: Significant growth across the businessLSE:0FDBNavamedic Asa
07/08/202312:40PR Newswire (US)Navamedic ASA: Invitation to 2023 2nd quarter presentationLSE:0FDBNavamedic Asa
01/06/202311:43PR Newswire (US)Navamedic ASA: Minutes of Annual General MeetingLSE:0FDBNavamedic Asa
31/05/202314:42PR Newswire (US)Updated recommendation by the nomination committee of Navamedic ASALSE:0FDBNavamedic Asa
26/05/202308:23PR Newswire (US)Navamedic to own a total of 96.33 per cent of shares in Sensidose following closing of public offerLSE:0FDBNavamedic Asa
11/05/202312:15PR Newswire (US)Navamedic ASA: Notice of Annual General MeetingLSE:0FDBNavamedic Asa
11/05/202308:57PR Newswire (US)Navamedic ASA Q1 2023: Another strong quarterLSE:0FDBNavamedic Asa
10/05/202309:15PR Newswire (US)Navamedic increases the consideration to SEK 8.50 in cash per share in its unconditional public offer and convenes an extraordinary general meeting of Sensidose AktiebolagLSE:0FDBNavamedic Asa
08/05/202311:25PR Newswire (US)Navamedic ASA: Invitation to 2023 1st quarter presentationLSE:0FDBNavamedic Asa
28/04/202313:57PR Newswire (US)Navamedic ASA: Annual Report for 2022LSE:0FDBNavamedic Asa
24/04/202305:34PR Newswire (US)Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose ABLSE:0FDBNavamedic Asa
29/03/202308:13PR Newswire (US)Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 millionLSE:0FDBNavamedic Asa
16/02/202309:00PR Newswire (US)Navamedic ASA: Q4 2022 financial resultsLSE:0FDBNavamedic Asa
13/02/202309:19PR Newswire (US)Navamedic ASA: Invitation to 2022 4th quarter presentationLSE:0FDBNavamedic Asa
23/11/202211:30PR Newswire (US)Navamedic ASA acquires innovative antibiotic product for hospital use in the Nordic regionLSE:0FDBNavamedic Asa
01/11/202208:43PR Newswire (US)Navamedic ASA: Q3 2022 financial resultsLSE:0FDBNavamedic Asa
25/10/202216:01PR Newswire (US)Navamedic ASA: Invitation to 2022 third quarter presentationLSE:0FDBNavamedic Asa
20/10/202209:24PR Newswire (US)Navamedic ASA launches ForlaxGO® - an innovative on-the-go product for the treatment of constipationLSE:0FDBNavamedic Asa
12/08/202208:48PR Newswire (US)Navamedic ASA: Q2 and first half 2022 financial resultsLSE:0FDBNavamedic Asa
09/08/202214:40PR Newswire (US)Navamedic ASA: Invitation to 2022 second quarter presentationLSE:0FDBNavamedic Asa
04/08/202214:27PR Newswire (US)Navamedic ASA - Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig®LSE:0FDBNavamedic Asa
04/07/202220:13PR Newswire (US)Navamedic ASA: Trading UpdateLSE:0FDBNavamedic Asa
01/06/202216:50PR Newswire (US)Navamedic ASA completes acquisition of Impolin AB and issues consideration sharesLSE:0FDBNavamedic Asa
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0FDB

La tua Cronologia

BIT
F12964
Vontobel Financial Produ...
NYSE
BAM
Brookfield Asset Managem...
NASDAQ
ILOG
NASDAQ
NEBS
NASDAQ
GRSH
Gores Holdings III
AMEX
SDY
SPDR S&P Dividend
NASDAQ
ABJYIXX
Bmo Harris Bank Na Cappe...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network